Based on our research, overexpression of FoxO3 enhances autophagy, inhibits oxidative stress and mTOR activation in the doxorubicin model; we propose that FoxO3 initiates autophagy, resulting in a favourable outcome that mitigates the effects of DOX‐induced cardiomyopathy. Here, MTOR is linked to cardiomyopathy.